- Home
- MHI vs TKNO Comparison
MHI vs TKNO Comparison
Compare MHI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHI
- TKNO
- Stock Information
- Founded
- MHI 2003
- TKNO 1996
- Country
- MHI United States
- TKNO United States
- Employees
- MHI N/A
- TKNO N/A
- Industry
- MHI Investment Managers
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- MHI Finance
- TKNO Health Care
- Exchange
- MHI Nasdaq
- TKNO Nasdaq
- Market Cap
- MHI 214.3M
- TKNO 211.6M
- IPO Year
- MHI N/A
- TKNO 2021
- Fundamental
- Price
- MHI $9.53
- TKNO $4.59
- Analyst Decision
- MHI
- TKNO Buy
- Analyst Count
- MHI 0
- TKNO 2
- Target Price
- MHI N/A
- TKNO $5.00
- AVG Volume (30 Days)
- MHI 98.8K
- TKNO 272.6K
- Earning Date
- MHI 01-01-0001
- TKNO 08-13-2024
- Dividend Yield
- MHI 4.09%
- TKNO N/A
- EPS Growth
- MHI N/A
- TKNO N/A
- EPS
- MHI 0.04
- TKNO N/A
- Revenue
- MHI N/A
- TKNO $34,940,000.00
- Revenue This Year
- MHI N/A
- TKNO $3.24
- Revenue Next Year
- MHI N/A
- TKNO $14.84
- P/E Ratio
- MHI $219.25
- TKNO N/A
- Revenue Growth
- MHI N/A
- TKNO N/A
- 52 Week Low
- MHI $6.93
- TKNO $1.16
- 52 Week High
- MHI $9.05
- TKNO $5.46
- Technical
- Relative Strength Index (RSI)
- MHI 64.78
- TKNO 57.12
- Support Level
- MHI $9.41
- TKNO $4.25
- Resistance Level
- MHI $9.50
- TKNO $5.04
- Average True Range (ATR)
- MHI 0.06
- TKNO 0.45
- MACD
- MHI -0.00
- TKNO -0.12
- Stochastic Oscillator
- MHI 90.32
- TKNO 28.22
About MHI Pioneer Municipal High Income Fund Inc.
Pioneer Municipal High Income Trust is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income exempt from regular federal income tax and capital appreciation. The trust invests in various sectors such as health, education, tobacco, facilities, transportation, utilities, airport, water, and other sectors.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.